Addiction-treatment centers pop up all over
Many of the providers are not traditional health systems, but rather small, for-profit startups attracted by a soaring demand for recovery services.
Health Care & Insurance
Articles
Drug cost bill advances but GOP resistance could spell trouble
A prescription drug compromise that would lower costs for Medicare recipients and save billions for Medicare and Medicaid cleared a key hurdle in the Senate on Thursday.
U.S. Sen. Todd Young, others fight for progress on smoking
Young is out front nationally on a key anti-smoking platform: Raising the minimum age for buying tobacco to 21.
Anthem stock takes hit despite positive quarterly earnings report
Indianapolis-based Anthem Inc. topped second quarter expectations and raised its 2019 forecast again. The health insurer also said Wednesday that the start of its new pharmacy benefit manager is going better than expected.
Senators unveil compromise to reduce drug costs for seniors
Iowa Republican Charles Grassley and Oregon Democrat Ron Wyden said the bill would for the first time limit drug copays for people with Medicare’s “Part D” prescription plan, by capping patients’ out-of-pocket costs.
Number of U.S. overdose deaths appears to be falling
U.S. overdose deaths last year likely fell for the first time in nearly three decades, preliminary statistics suggest.
Anthem’s fight with doctors shows risks for surprise-billing fix
Doctors fighting a reimbursement battle with one of the biggest U.S. health insurers want to make sure that ending surprise medical bills doesn’t come at the expense of their pay.
Carmel adds vaping to public smoking ban
Violators could be charged up to $50 for their first violation and up to $500 for more violations in the same year.
Trump kills key drug price proposal he once embraced
The drug rebate rule would have ended a widespread practice in which drugmakers give rebates to insurance middlemen in government programs such as Medicare. The idea was to channel that money to consumers instead.
White House yanks drug ‘rebate’ plan after poor review from CBO
The nonpartisan Congressional Budget Office estimated the plan would have little impact on manufacturer prices and cost Medicare $177 billion over 10 years by leading to higher premiums subsidized by taxpayers.
Lilly losing two senior executives, including Bio-Medicines chief
Lilly shares dropped 4.6 percent in early trading after the company said Christi Shaw was leaving and Mike Harrington planned to retire.
Startup claims breakthrough in gauging pain
MindX founders think they’ve found a scientific way to measure pain and other hard-to-quantify mental health conditions, such as suicide risk, depression and post-traumatic stress disorder.
Validity of Obama health care law at issue in appeal hearing
A federal appeals court seemed inclined Tuesday to rule that the core provision of President Barack Obama’s signature health care law is unconstitutional.
Elanco in merger talks with pharmaceutical giant Bayer, sources say
The multibillion-dollar merger would combine Elanco, the fourth-largest global player in animal health, with Bayer’s pet-health division, which ranks fifth in veterinary medicine, Reuters reported. The combination would create a dominant force in the industry.
Latest Obamacare legal battle plays out in federal appeals court
The fate of former President Barack Obama's signature health care law, and its coverage and insurance protections for millions of Americans, is again being argued in a case that appears destined for the Supreme Court.
Judge strikes down rule requiring drug ads to reveal prices
Responding to a lawsuit by Eli Lilly and two other companies, a federal judge Monday blocked a major White House initiative on prescription drug costs, saying the Trump administration lacked the legal authority to require drugmakers to disclose their prices in TV ads.
Local investment adviser loses state insurance license
The owner of Pendleton-based Steele Financial Inc., who is already in hot water with the Financial Industry Regulatory Authority and the SEC, has been stripped of her license by the Indiana Department of Insurance.
IBJ Podcast: This IU pediatrician is a health care myth buster
Should you avoid red meat? No. Should you strive for 10,000 steps a day? Not unless you just want to. So says Dr. Aaron Carroll, a pediatrician and researcher at the Indiana University School of Medicine who sees it as his life’s calling to debunk what he considers health myths and weak medical research.
IU Health executive Kitchell leaving ‘for other opportunities’
Ryan Kitchell oversees a wide variety of business operations at the state’s largest health system. His departure comes as IU Health is in the midst of numerous capital projects.
Debunking medical myths all in a day’s work for IU’s Dr. Aaron Carroll
Carroll uses Twitter, a New York Times column, blog post, podcast, videos and books to publish his findings on just about any health issue he thinks needs explaining or correcting.